Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Nutr Metab Cardiovasc Dis ; 20(3): 186-94, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19502018

RESUMO

BACKGROUND AND AIM: The intake of wholemeal foods is consistently associated with reduced risk of type 2 diabetes and cardiovascular diseases in epidemiological studies, although the mechanisms of this association are unclear. Here we aim to compare in healthy subjects the metabolic effects of a diet rich in wholemeal wheat foods versus one based on the same products in refined form. METHODS AND RESULTS: Fifteen healthy individuals (12 M/3 F), mean age 54.5+/-7.6 years, BMI 27.4+/-3.0 kg/m(2) (mean+/-SD), participated in a randomized sequential crossover study. After 2 weeks run-in, participants were randomly assigned to two isoenergetic diets with similar macronutrient composition, one rich in wholemeal wheat foods and the other with the same foods but in refined form (cereal fibre 23.1 vs. 9.8 g/day). After the two treatment periods (each lasting 3 weeks) plasma glucose and lipid metabolism, antioxidant activity, acetic acid, magnesium, adipokines, incretins and high-sensitivity C-reactive protein (hs-CRP) were measured at fasting and for 4h after a standard test meal (kcal 1103, protein 12%, CHO 53%, fat 35%) based on wholemeal or refined wheat foods, respectively. After the two diets there were no differences in fasting nor in postprandial plasma parameter responses; only glucose was slightly but significantly lower at 240 min after the refined wheat food meal compared to the wholemeal wheat food meal. Conversely, after the wholemeal diet both total (-4.3%; p<0.03) and LDL (-4.9%; p<0.04) cholesterol levels were lower than after the refined wheat diet at fasting. CONCLUSIONS: Consumption of wholemeal wheat foods for 3 weeks reduces significantly fasting plasma cholesterol as well as LDL cholesterol levels in healthy individuals without major effects on glucose and insulin metabolism, antioxidant status and sub-clinical inflammation markers.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Dieta , Triticum , Glicemia/análise , Pressão Sanguínea , Peso Corporal , Peptídeo C/sangue , Colesterol/sangue , LDL-Colesterol/sangue , Estudos Cross-Over , Jejum , Feminino , Manipulação de Alimentos , Polipeptídeo Inibidor Gástrico/sangue , Grelina/sangue , Humanos , Insulina/sangue , Resistência à Insulina , Leptina/sangue , Masculino , Pessoa de Meia-Idade , Fatores de Risco
2.
Int J Food Microbiol ; 125(3): 286-92, 2008 Jul 31.
Artigo em Inglês | MEDLINE | ID: mdl-18524406

RESUMO

The human intestinal microbiota plays a pivotal role in human nutrition and health by promoting the supply of nutrients, preventing pathogen colonization and shaping and maintaining normal mucosal immunity. The depletion of the individual microbiota can result in a higher susceptibility to enteropathogenic bacteria infection. In order to reduce this risk, the use of food supplements containing probiotic bacteria has been recently addressed. In this paper, we investigate the protective role toward enteropathogen infection of probiotic strains belonging to Lactobacillus and Bifidobacterium. According to our experimental data, Lactobacillus acidophilus Bar13, L. plantarum Bar10, Bifidobacterium longum Bar33 and B. lactis Bar30 were effective in displacing the enteropathogens Salmonella typhimurium and Escherichia coli H10407 from a Caco-2 cell layer. Moreover, L. acidophilus Bar13 and B. longum Bar33 have been assessed for their immunomodulatory activity on IL-8 production by HT29 cells. Both strains showed the potential to protect enterocytes from an acute inflammatory response. These probiotic strains are potential candidates for the development of new functional foods helpful in counteracting enteropathogen infections.


Assuntos
Aderência Bacteriana/fisiologia , Bifidobacterium/fisiologia , Interleucina-8/biossíntese , Mucosa Intestinal , Lactobacillus/fisiologia , Ligação Competitiva , Células CACO-2 , Linhagem Celular , Contagem de Colônia Microbiana , Escherichia coli Êntero-Hemorrágica/crescimento & desenvolvimento , Células HT29 , Humanos , Mucosa Intestinal/imunologia , Mucosa Intestinal/microbiologia , Probióticos , Salmonella typhimurium/crescimento & desenvolvimento
3.
Food Microbiol ; 24(2): 150-4, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17008158

RESUMO

Sourdough fermentation is considered to play a key role to get improved flavour, texture, nutritional and shelf-life properties of bakery products. Since few years Barilla R&D has been focusing on liquid sourdough fermentation which may deserve several advantages with respect to traditional processes. The results showed that the micro-biota of sourdough markedly influences flavour and texture of bakery products. Particular attention has been paid to lactic acid bacteria and yeasts. Selected lactic acid bacteria and yeasts were tested in sourdough liquid fermentation as single strain or in association. The parameters of fermentations were optimized and standardized to set up a laboratory plant liquid fermentation. Only a few strains of lactic acid bacteria were found to be suitable for liquid fermentation alone or in association with yeasts. Fermentations were carried out at pilot plant and an industrial technology was developed. This work describes the results found for the organoleptic profile of an industrial bread started with liquid sourdough with respect to bakers' yeast bread without sourdough addition.


Assuntos
Pão/microbiologia , Pão/normas , Fermentação , Microbiologia Industrial , Lactobacillus/crescimento & desenvolvimento , Saccharomyces cerevisiae/crescimento & desenvolvimento , Reatores Biológicos , Contagem de Colônia Microbiana , Microbiologia de Alimentos , Lactobacillus/metabolismo , Saccharomyces cerevisiae/metabolismo , Especificidade da Espécie , Paladar , Temperatura , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA